1. Home
  2. ARWR vs TX Comparison

ARWR vs TX Comparison

Compare ARWR & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • TX
  • Stock Information
  • Founded
  • ARWR 2003
  • TX 1961
  • Country
  • ARWR United States
  • TX Luxembourg
  • Employees
  • ARWR N/A
  • TX N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • TX Steel/Iron Ore
  • Sector
  • ARWR Health Care
  • TX Industrials
  • Exchange
  • ARWR Nasdaq
  • TX Nasdaq
  • Market Cap
  • ARWR 5.9B
  • TX 6.2B
  • IPO Year
  • ARWR 1993
  • TX 2006
  • Fundamental
  • Price
  • ARWR $40.96
  • TX $35.92
  • Analyst Decision
  • ARWR Strong Buy
  • TX Buy
  • Analyst Count
  • ARWR 8
  • TX 6
  • Target Price
  • ARWR $47.75
  • TX $35.25
  • AVG Volume (30 Days)
  • ARWR 1.7M
  • TX 266.2K
  • Earning Date
  • ARWR 11-25-2025
  • TX 10-28-2025
  • Dividend Yield
  • ARWR N/A
  • TX 7.55%
  • EPS Growth
  • ARWR N/A
  • TX 635.85
  • EPS
  • ARWR N/A
  • TX 2.97
  • Revenue
  • ARWR $572,976,000.00
  • TX $15,710,564,000.00
  • Revenue This Year
  • ARWR $21,287.22
  • TX N/A
  • Revenue Next Year
  • ARWR N/A
  • TX $6.99
  • P/E Ratio
  • ARWR N/A
  • TX $12.03
  • Revenue Growth
  • ARWR 2816.20
  • TX N/A
  • 52 Week Low
  • ARWR $9.57
  • TX $24.00
  • 52 Week High
  • ARWR $43.69
  • TX $38.15
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 60.87
  • TX 51.75
  • Support Level
  • ARWR $37.35
  • TX $35.20
  • Resistance Level
  • ARWR $42.00
  • TX $36.55
  • Average True Range (ATR)
  • ARWR 2.18
  • TX 1.10
  • MACD
  • ARWR -0.28
  • TX -0.09
  • Stochastic Oscillator
  • ARWR 61.35
  • TX 59.39

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.

Share on Social Networks: